Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products
Open Access
- 2 April 2025
- journal article
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (5) , e70072
Abstract
The present research study describes the Venetoclax (VEN)‐related substances test method using RP‐HPLC/DAD techniques. It was developed and validated according to ICH Q14 and Q2(R2) guidelines. The substances were separated using an X‐Bridge Phenyl column (150 mm × 4.6 mm, 3.5 μm) and a gradient program. The mobile phase A, consist 0.02 mM Na2HPO4 (pH 8.0) buffer and acetonitrile in an 80:20 v/v ratio. Mobile phase B was prepared using a 75:25 v/v mixture of acetonitrile and a pH 8.0 buffer and well mixed. The flow rate remains constant at 1.0 mL/min, traversing an appropriate gradient program. The VEN and its impurities were detected at 280 nm, with an injection volume of 15 μL and a runtime of 130 min. Moreover, we identified proper degradation impurities and sensitivity of VEN due to forced‐degradation study experiments. The linearity and range of the testing procedure were validated by computing r2 values over 0.999. All organic impurities were recovered at a rate of 97.6%–106.0% with a relative standard deviation of 0.11%–4.35%. A robustness test was conducted utilizing the AQbD methodology. The proposed method was stability‐indicating in nature and can be used for commercial samples in the pharmaceutical industries.Keywords
This publication has 16 references indexed in Scilit:
- Stability indicating RP‐HPLC method development and validation for quantification of impurities in gonadotropin‐releasing hormone (Elagolix): Robustness study by quality by designBiomedical Chromatography, 2024
- Development and validation of apalutamide‐related substances method in solid dosage forms using HPLCBiomedical Chromatography, 2023
- QbD‐based stability‐indicating liquid chromatography (RP‐HPLC) method for the determination of flurbiprofen in cataplasmBiomedical Chromatography, 2023
- Development of a Stability-Indicating Analytical Method for Determination of Venetoclax Using AQbD PrinciplesACS Omega, 2020
- Venetoclax for the treatment of multiple myelomaExpert Review of Hematology, 2018
- Venetoclax: A new wave in hematooncologyExperimental Hematology, 2018
- Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax StoryJournal of Pharmaceutical Sciences, 2018
- Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor VenetoclaxCancer Discovery, 2017
- Development of validated stability-indicating assay methods—critical reviewJournal of Pharmaceutical and Biomedical Analysis, 2002
- Quality of biotechnological products: stability testing of biotechnological/biological products. Annex to the ICH Harmonised Tripartite Guideline for the Stability Testing of New Drug Substances and Products.1998